Lücker Peter, Stahlheber-Dilg Bodo A
Institut für Klinische Pharmakologie Bobenheim.
Br J Nurs. 2003;12(22):1345-51. doi: 10.12968/bjon.2003.12.22.11898.
Pain related to the insertion of intravenous catheters is a major issue for many patients. This study investigated differences in pain on insertion for three different catheters - Optiva 1, Biovalve and Venflon 2 - as assessed by 100 volunteers. Clinicians also assessed a variety of parameters related to their overall ease of use. This study demonstrates that Optiva 2 can offer significant benefits for both patient and clinician. Pain on insertion was significantly lower with Optiva 2 than with Venflon 2, but comparable with Biovalve. Ease of insertion and flashback were significantly better for Optiva 2 than for Venflon 2, but similar to Biovalve. For the parameters 'ease of catheter advancement' and 'overall ease of use', the operators rated Optiva 2 significantly better than Biovalve and Venflon 2.
对于许多患者来说，与静脉导管插入相关的疼痛是一个主要问题。本研究调查了100名志愿者对三种不同导管（Optiva 1、Biovalve和Venflon 2）插入时疼痛的差异。临床医生还评估了与它们整体易用性相关的各种参数。本研究表明，Optiva 2对患者和临床医生都能带来显著益处。Optiva 2插入时的疼痛明显低于Venflon 2，但与Biovalve相当。Optiva 2的插入便利性和回血情况明显优于Venflon 2，但与Biovalve相似。对于“导管推进便利性”和“整体易用性”参数，操作人员对Optiva 2的评价明显高于Biovalve和Venflon 2。
